1-2 of 2
Ursula Becker, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Carolina Reyes, PhD, Gregory Gazauskas, PhD, Ursula Becker, MSc, Santiago Moreno, David L. Veenstra, PharmD, PhD
Journal: Blood
Blood (2014) 124 (21): 1324.
https://doi.org/10.1182/blood.V124.21.1324.1324
Published: 2014
Journal Articles

Obinutuzumab and Chlorambucil Versus Chlorambucil Monotherapy for Treatment of Previously Untreated Chronic Lymphocytic Leukemia Where Fludarabine-Based Chemotherapy Is Considered Inappropriate: A Canadian Cost-Utility Analysis

Heather Cameron, PhD, Melissa Thompson, John-Paul Marino, Michael Duong, Ursula Becker, MSc, Christof Wiesner, PhDMPH
Journal: Blood
Blood (2014) 124 (21): 1288.
https://doi.org/10.1182/blood.V124.21.1288.1288
Published: 2014